Hartono John, Lavingia Bhavna, Stastny Peter, Senitko Martin, Vazquez Miguel, Arenas Juan, Lu Christopher
Division of Nephrology, Department of Internal Medicine, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd, Dallas, Texas, USA.
J Med Case Rep. 2009 Jan 30;3:41. doi: 10.1186/1752-1947-3-41.
Hyperacute rejection may be prevented by avoiding the transplantation of kidneys into patients with pre-existing anti-donor Class I human leukocyte antigen antibodies. However, the role of anti-donor-Class II-human leukocyte antigen-DQ antibodies is not established. The question is ever more relevant as more sensitive cross-matching techniques detect many additional antibodies during the final crossmatch. We now report successful renal transplantation of a patient who had pre-existing antibodies against his donor's human leukocyte antigen-DQ5.
Our patient, a Caucasian man, was 34 years of age when he received his first deceased donor renal transplant. After 8 years, his first transplant failed from chronic allograft dysfunction and an earlier bout of Banff 1A cellular rejection. The second deceased donor kidney transplant was initially allocated to the patient due to a 0 out of 6 mismatch. The B cell crossmatch was mildly positive, while the T Cell crossmatch was negative. Subsequent assays showed that the patient had preformed antibodies for human leukocyte antigen DQ5 against his second donor. Despite having preformed antibodies against the donor, the patient continues to have excellent allograft function two years after his second renal transplant.
The presence of pre-existing antibodies against human leukocyte antigen DQ5 does not preclude transplantation. The relevance of having other antibodies against class II human leukocyte antigens prior to transplantation remains to be studied.
通过避免将肾脏移植给预先存在抗供体I类人类白细胞抗原抗体的患者,可预防超急性排斥反应。然而,抗供体II类人类白细胞抗原-DQ抗体的作用尚未明确。随着更敏感的交叉配型技术在最终交叉配型过程中检测到更多额外抗体,这个问题变得愈发重要。我们现在报告一例预先存在针对其供体人类白细胞抗原-DQ5抗体的患者成功进行肾移植的病例。
我们的患者是一名34岁的白种男性,首次接受尸体供肾移植。8年后,他的首次移植因慢性移植物功能障碍和早期一次班夫1A类细胞性排斥反应而失败。第二次尸体供肾移植最初因6个错配位点为0而分配给该患者。B细胞交叉配型呈轻度阳性,而T细胞交叉配型为阴性。后续检测显示该患者针对其第二个供体预先存在人类白细胞抗原DQ5抗体。尽管预先存在针对供体的抗体,但该患者在第二次肾移植两年后仍具有出色的移植物功能。
预先存在针对人类白细胞抗原DQ5的抗体并不排除移植。移植前存在其他针对II类人类白细胞抗原的抗体的相关性仍有待研究。